Dr. Stephen Barnes spent most of March at home, recovering from COVID-19. Despite being temporarily sidelined, he’s now back at the hospital bedside, and his potential role in helping patients through the pandemic is even greater.
As a survivor, Barnes’ blood contains the antibodies – proteins produced mainly by plasma cells that the immune system uses to combat harmful pathogens – that allowed him to overcome the novel coronavirus.
An investigational treatment called convalescent plasma aims to harness the power of such antibodies to help critically ill patients who are struggling to overcome COVID-19 on their own.
“Part of the reason physicians do what we do is to serve the community, and I just felt like convalescent plasma was another way to do that,” said Barnes, an anesthesiologist who practices at CHI Memorial and Parkridge health systems.
“I had mild symptoms, but it’s scary because you don’t know who’s going to be really, really sick,” Barnes said by phone. “That’s what was really pushing me and an extension of why I chose to be a doctor – to turn around and give back to those who are having a tougher time.”
